Sell Torrent Pharmaceuticals, target Rs 1650: Kunal Bothra

Independent analyst Kunal Bothra has a sell call on Torrent Pharmaceuticals Ltd. with a target price of Rs 1650.0 . The current market price of Torrent Pharmaceuticals Ltd. is Rs 1681.6 Time period given by the analyst is Intra Day when Torrent Pharmaceuticals Ltd. price can reach the defined target. Kunal Bothra recommended to keep stoploss at Rs 1700. Torrent Pharmaceuticals Ltd., incorporated in 1972, is a largecap company with a market cap of Rs 28456.70 crore.

Torrent Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 4141.90 Crore to Sales Value (97.49 % of Total Sales), Export Incentives which contributed Rs 60.31 Crore to Sales Value (1.41 % of Total Sales) and Other Operating Revenue which contributed Rs 46.03 Crore to Sales Value (1.08 % of Total Sales)for the year ending 31-Mar-2018.

For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 1834.00 Crore, up 9.17 % from last quarter Sales of Rs 1680.00 Crore and up 36.05 % from last year same quarter Sales of Rs 1348.00 Crore Company has reported net profit after tax of Rs 163.00 Crore in latest quarter. The company’s top management includes Dr.Chaitanya Dutt, Mr.Haigreve Khaitan, Mr.Pradeep Bhargava, Mr.Samir Mehta, Mr.Shailesh Haribhakti, Mr.Sudhir Mehta, Ms.Ameera Shah. Company has BSR & Co. LLP as its auditoRs As on 30-06-2018, the company has a total of 169,222,720 shares outstanding.